Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 144.88M | 162.02M | 156.85M | 235.20M | 234.50M | 96.03M |
Gross Profit | 92.99M | 90.54M | 81.14M | 89.65M | 115.99M | 61.74M |
EBITDA | -10.24M | -49.62M | -143.21M | -726.85M | -182.94M | -68.24M |
Net Income | -23.67M | -49.60M | -185.32M | -768.61M | -171.34M | -74.62M |
Balance Sheet | ||||||
Total Assets | 183.07M | 178.01M | 206.06M | 432.76M | 1.11B | 215.75M |
Cash, Cash Equivalents and Short-Term Investments | 88.30M | 98.48M | 136.92M | 354.15M | 547.23M | 151.72M |
Total Debt | 2.38M | 3.83M | 149.69M | 231.98M | 232.31M | 16.58M |
Total Liabilities | 205.64M | 181.99M | 179.12M | 268.84M | 301.89M | 52.41M |
Stockholders Equity | -22.57M | -56.36M | -19.24M | 123.17M | 774.64M | 163.34M |
Cash Flow | ||||||
Free Cash Flow | -3.13M | -22.89M | -128.21M | -192.49M | -129.39M | -66.33M |
Operating Cash Flow | 11.21M | -13.04M | -127.62M | -190.42M | -127.50M | -65.01M |
Investing Cash Flow | 2.25M | 45.40M | 127.31M | 99.43M | -633.91M | -7.92M |
Financing Cash Flow | -19.38M | -21.06M | -90.96M | 2.22M | 933.57M | 90.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $1.21B | 9.57 | 21.16% | ― | 6.79% | 12.97% | |
62 Neutral | $745.27M | 74.99 | 5.33% | ― | 4.51% | 8241.83% | |
62 Neutral | $842.57M | ― | -10.16% | ― | 7.96% | 5.67% | |
61 Neutral | $35.97B | 6.65 | -7.26% | 1.99% | 8.60% | -7.54% | |
59 Neutral | $598.04M | 289.58 | 5.20% | ― | 30.92% | ― | |
58 Neutral | $1.02B | ― | -15.34% | ― | 7.43% | 16.14% | |
50 Neutral | $736.48M | ― | -93.00% | ― | -4.76% | 67.62% |
On August 7, 2025, Blend Labs announced its financial results for the second quarter of 2025, highlighting a fourth consecutive quarter of year-over-year revenue growth and non-GAAP profitability. The company reported a total revenue of $31.5 million, driven by a 43% increase in Consumer Banking Suite revenue, despite a slight decrease in Mortgage Suite revenue. Blend’s sales momentum was strong, with 23 new or expanded deals, including three new independent mortgage banks. The company also achieved a record remaining performance obligations balance of $190.4 million. Additionally, Blend announced the sale of Title365 to Covius, aiming to transition to a higher-margin partnership model for its title services. The company provided guidance for the third quarter of 2025, expecting marginally higher U.S. mortgage originations compared to the second quarter.
The most recent analyst rating on (BLND) stock is a Buy with a $3.90 price target. To see the full list of analyst forecasts on Blend Labs stock, see the BLND Stock Forecast page.
On August 7, 2025, Blend Labs announced the appointment of Jason Ream as the new Head of Finance and Administration, succeeding Amir Jafari. Ream, who brings over 25 years of experience in financial leadership roles, is expected to drive sustainable growth and operational discipline at Blend. This leadership transition is seen as a pivotal step in Blend’s growth and profitability journey, with Ream’s expertise aligning with the company’s strategic direction to evolve as a durable platform partner in the banking and lending industry.
The most recent analyst rating on (BLND) stock is a Buy with a $3.90 price target. To see the full list of analyst forecasts on Blend Labs stock, see the BLND Stock Forecast page.
On June 11, 2025, Blend Labs, Inc. held its annual meeting of stockholders where two main proposals were voted on. The stockholders elected seven directors to serve until the next annual meeting and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (BLND) stock is a Buy with a $3.90 price target. To see the full list of analyst forecasts on Blend Labs stock, see the BLND Stock Forecast page.
On June 9, 2025, Blend Labs announced its decision to sell its title insurance business, Title365 Holding Co., to Covius Services, LLC. This strategic move, pending regulatory approvals, is expected to impact Blend’s operational focus and market positioning in the coming months.
The most recent analyst rating on (BLND) stock is a Buy with a $3.90 price target. To see the full list of analyst forecasts on Blend Labs stock, see the BLND Stock Forecast page.